Marshall Wace
PDLI

Marshall Wace’s PDL BioPharma, Inc. PDLI Stock Holding History

Marshall Wace’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-165,921
Closed -$539K – 2294
2019
Q4 		$539K Sell
165,921
-78,580
-32% -$228K ﹤0.01% 1141
2019
Q3 		$528K Sell
244,501
-253,698
-51% -$678K ﹤0.01% 1095
2019
Q2 		$1.56M Buy
498,199
+455,193
+1,058% +$1.48M 0.01% 837
2019
Q1 		$160K Buy
+43,006
New +$145K ﹤0.01% 1363
2016
Q1 		– Sell
-46,678
Closed -$165K – 1348
2015
Q4 		$165K Sell
46,678
-108,922
-70% -$456K ﹤0.01% 928
2015
Q3 		$783K Buy
+155,600
New +$892K 0.01% 667

Other funds holding PDLI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ECM
Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return